Rice Hall James & Associates’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Sell
8,096
-1,913
-19% -$103K 0.03% 214
2026
Q1
$523K Sell
10,009
-82
-0.8% -$4.92K 0.03% 222
2025
Q4
$593K Sell
10,091
-12
-0.1% -$729 0.03% 215
2025
Q3
$562K Sell
10,103
-31
-0.3% -$1.66K 0.03% 218
2025
Q2
$521K Buy
10,134
+73
+0.7% +$3.67K 0.03% 217
2025
Q1
$590K Buy
10,061
+41
+0.4% +$2.78K 0.03% 212
2024
Q4
$722K Sell
10,020
-4
-0% -$294 0.04% 211
2024
Q3
$801K Sell
10,024
-214
-2% -$16.1K 0.04% 210
2024
Q2
$734K Sell
10,238
-61
-0.6% -$4.49K 0.04% 212
2024
Q1
$725K Sell
10,299
-4,133
-29% -$296K 0.04% 218
2023
Q4
$1.11M Hold
14,432
0.06% 211
2023
Q3
$982K Sell
14,432
-8
-0.1% -$632 0.06% 205
2023
Q2
$1.18M Sell
14,440
-8,014
-36% -$644K 0.07% 208
2023
Q1
$1.67M Sell
22,454
-246
-1% -$19K 0.09% 206
2022
Q4
$1.88M Sell
22,700
-4,332
-16% -$344K 0.11% 194
2022
Q3
$1.92M Sell
27,032
-312
-1% -$27K 0.11% 189
2022
Q2
$2.37M Sell
27,344
-520
-2% -$48.7K 0.11% 178
2022
Q1
$3.02M Sell
27,864
-364
-1% -$37.6K 0.12% 161
2021
Q4
$3.65M Hold
28,228
0.13% 155
2021
Q3
$3.42M Sell
28,228
-800
-3% -$97.4K 0.13% 126
2021
Q2
$3.27M Sell
29,028
-4,580
-14% -$482K 0.12% 132
2021
Q1
$3.21M Sell
33,608
-3,864
-10% -$353K 0.1% 139
2020
Q4
$2.98M Sell
37,472
-6,232
-14% -$451K 0.1% 144
2020
Q3
$2.71M Sell
43,704
-2,716
-6% -$177K 0.11% 133
2020
Q2
$3.06M Sell
46,420
-884
-2% -$52.9K 0.13% 125
2020
Q1
$2.24M Sell
47,304
-892
-2% -$44.6K 0.13% 131
2019
Q4
$2.65M Sell
48,196
-340
-0.7% -$17.8K 0.09% 139
2019
Q3
$2.37M Sell
48,536
-4,440
-8% -$223K 0.08% 145
2019
Q2
$2.76M Sell
52,976
-608
-1% -$30.6K 0.09% 148
2019
Q1
$2.66M Sell
53,584
-5,040
-9% -$227K 0.09% 155
2018
Q4
$2.12M Sell
58,624
-716
-1% -$29.9K 0.08% 158
2018
Q3
$3.03M Sell
59,340
-10,504
-15% -$465K 0.11% 137
2018
Q2
$2.58M Sell
69,844
-6,900
-9% -$263K 0.09% 152
2018
Q1
$2.9M Sell
76,744
-340
-0.4% -$12K 0.11% 134
2017
Q4
$2.5M Sell
77,084
-9,092
-11% -$289K 0.1% 163
2017
Q3
$2.6M Sell
86,176
-8,000
-8% -$237K 0.12% 153
2017
Q2
$2.77M Sell
94,176
-8,540
-8% -$233K 0.12% 132
2017
Q1
$2.61M Sell
102,716
-1,932
-2% -$49.9K 0.13% 140
2016
Q4
$2.69M Sell
104,648
-760
-0.7% -$20K 0.14% 131
2016
Q3
$2.89M Sell
105,408
-2,192
-2% -$60.2K 0.15% 125
2016
Q2
$3.03M Sell
107,600
-2,748
-2% -$70.6K 0.17% 108
2016
Q1
$2.61M Buy
110,348
+3,532
+3% +$77.8K 0.15% 121
2015
Q4
$2.4M Sell
106,816
-39,596
-27% -$903K 0.14% 143
2015
Q3
$3.38M Sell
146,412
-3,512
-2% -$88.1K 0.22% 102
2015
Q2
$3.69M Sell
149,924
-7,932
-5% -$198K 0.21% 106
2015
Q1
$3.96M Buy
157,856
+31,412
+25% +$747K 0.23% 108
2014
Q4
$2.92M Sell
126,444
-1,376
-1% -$31.5K 0.18% 154
2014
Q3
$2.99M Sell
127,820
-316
-0.2% -$7.41K 0.21% 121
2014
Q2
$2.96M Sell
128,136
-11,548
-8% -$255K 0.2% 128
2014
Q1
$2.98M Sell
139,684
-448
-0.3% -$10.1K 0.22% 126
2013
Q4
$3.32M Buy
+140,132
New +$3.04M 0.24% 110

Other funds holding TECH

Rice Hall James & Associates's TECH Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Bio-Techne (TECH) stake by 19% in Q2 2026, selling an estimated $103K and leaving 8,096 shares worth $572K. The position accounts for 0.03% of the portfolio, ranked #214.

Rice Hall James & Associates first reported a position in TECH in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.96M in Q1 2015. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Rice Hall James & Associates held 8,096 shares of Bio-Techne worth $572K as of Q2 2026.
  • Rice Hall James & Associates sold 1,913 Bio-Techne shares in Q2 2026, an estimated $103K.
  • Bio-Techne made up 0.03% of Rice Hall James & Associates's portfolio in Q2 2026, its #214 holding.
  • Rice Hall James & Associates first reported a position in Bio-Techne in Q4 2013 and has held it in 51 quarters since.
  • Rice Hall James & Associates's Bio-Techne position peaked at $3.96M in Q1 2015.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.